乳腺癌区域淋巴结放疗后症状负担与早期淋巴管异常的关联
本研究前瞻性纳入60例接受腋窝清扫与区域淋巴结放疗的乳腺癌患者,在基线、术后及放疗后6、12、18个月行体积测量、近红外荧光淋巴成像(NIRF-LI)和患者报告淋巴水肿结局(PRLO)调查。结果显示真皮回流与临床淋巴水肿从基线至18个月分别由10%升至85%、由0%升至40%,真皮回流与LSIDS部分亚量表及QuickDASH评分相关。
要点
- 真皮回流与临床淋巴水肿从基线至18个月分别由10%升至85%、由0%升至40%。
- 调整模型中,软组织感觉、神经感觉和功能LSIDS亚量表评分与真皮回流存在关联(均P<.05)。
- 真皮回流与淋巴水肿均与QuickDASH评分相关(P<.05)。
核心结论
- 在这一高危队列中,早期淋巴水肿体征非常普遍,且症状负担较基线增加。
- 真皮回流与患者报告淋巴水肿结局指标相关,提示NIRF-LI或可用于识别区域淋巴结放疗后适合早期干预试验的患者。
研究设计与样本
- 前瞻性研究,纳入计划接受腋窝清扫和区域淋巴结放疗的乳腺癌患者,共60例完成至少2组测量和调查并纳入分析。
- 在基线、术后及放疗后6、12、18个月进行体积测量、近红外荧光淋巴成像(NIRF-LI)和患者报告淋巴水肿结局调查(LSIDS和QuickDASH)。
- 临床淋巴水肿定义为手臂体积较基线增加≥5%;采用方差分析评估时间趋势,采用线性混合效应模型评估调查应答与真皮回流及淋巴水肿的关联。
主要发现
- 54%的患者为cT3-T4期疾病,53%为cN3期疾病,75%的患者体重指数>25。
- 真皮回流从基线的10%升至18个月时的85%,临床淋巴水肿从基线的0%升至18个月时的40%。
- 在调整模型中,软组织感觉、神经感觉和功能LSIDS亚量表评分与真皮回流存在关联(均P<.05)。
- 真皮回流和淋巴水肿均与QuickDASH评分相关(P<.05)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Dermal backflow visualized on near-infrared fluorescence lymphatic imaging (NIRF-LI) signals preclinical lymphedema that precedes the development of volumetrically defined lymphedema. We sought to evaluate whether dermal backflow correlates with patient-reported lymphedema outcomes (PRLO) surveys in breast cancer patients treated with regional nodal irradiation (RNI). METHODS AND MATERIALS: Patients with breast cancer planned for axillary dissection and RNI prospectively underwent perometry, NIRF-LI, and PRLOs (the Lymphedema Symptom Intensity and Distress Survey [LSIDS] and QuickDASH) at baseline, after surgery, and at 6, 12, and 18 months after radiation. Clinical lymphedema was defined as an arm volume increase ≥5% over baseline. Trends over time were assessed using analysis of variance testing. The association between survey responses and both dermal backflow and lymphedema was assessed using a linear mixed-effects model. RESULTS: Sixty participants completed at least 2 sets of measurements and surveys and were eligible for analysis. Fifty-four percent of patients had cT3-T4 disease, 53% cN3 disease, and 75% had a body mass index >25. Dermal backflow and clinical lymphedema increased from 10% to 85% and from 0% to 40%, respectively, from baseline to 18 months. In the adjusted model, soft tissue sensation, neurologic sensation, and functional LSIDS subscale scores were associated with presence of dermal backflow (all P < .05). Both dermal backflow and lymphedema were associated with QuickDASH score (P < .05). CONCLUSIONS: In this high-risk cohort, we found highly prevalent early signs of lymphedema, with increased symptom burden from baseline. Presence of dermal backflow correlated with PRLO measures, highlighting a potential NIRF-LI use to identify patients for early intervention trials after RNI.
引用
- Yoder AK, Xu T, Youssef P, et al. Association Between Symptom Burden and Early Lymphatic Abnormalities After Regional Nodal Irradiation for Breast Cancer. Pract Radiat Oncol. 2023. PMID: 37914083. doi:10.1016/j.prro.2023.10.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。